Author:
Richardson Paul G.,Laubach Jacob,Mitsiades Constantine S.,Schlossman Robert,Hideshima Teru,Redman Katherine,Chauhan Dharminder,Ghobrial Irene M.,Munshi Nikhil,Anderson Kenneth C.
Reference42 articles.
1. Lenalidomide maintenance after transplantation for myeloma;Attal;Journal of Clinical Oncology (ASCO Meeting Abstracts),2010a
2. Maintenance treatment with lenalidomide after transplantation for myeloma: final analysis of the IFM 2005-02;Attal;Blood (ASH Annual Meeting Abstracts),2010b
3. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome;Avet-Loiseau;Blood,2007
4. Long-term outcome results of the first tandem autotransplant trial for multiple myeloma;Barlogie;British Journal of Haematology,2006
5. Ninety percent sustained complete response (CR) rate projected 4 years after onset of CR in gene expression profiling (GEP)-defined low-risk multiple myeloma (MM) treated with total therapy 3 (TT3): basis for GEP-risk-adapted TT4 and TT5;Barlogie;Blood (ASH Annual Meeting Abstracts),2008
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献